Hvsen Biotechnology Co., Ltd. announced a private placement to issue common shares on April 3, 2024. The transaction has been approved in the 10th meeting of the third board of directors and the 8th meeting of the third board of supervisors and still need to be reviewed and approved by the company's shareholders' meeting, reviewed and approved by the Shenzhen Stock Exchange, and approved by the China Securities Regulatory Commission for registration before they can be implemented.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.48 CNY | +0.19% | +0.19% | +7.05% |
04-25 | Hvsen Biotechnology Co., Ltd. Proposes Final Cash Dividend for 2023 | CI |
04-24 | Hvsen Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.05% | 350M | |
-11.83% | 79.42B | |
+28.00% | 3.8B | |
-1.39% | 3.23B | |
+21.28% | 1.75B | |
-3.25% | 1.61B | |
-18.63% | 1.36B | |
-1.17% | 1.3B | |
-6.77% | 1.22B | |
+2.34% | 1.11B |
- Stock Market
- Equities
- 300871 Stock
- News Hvsen Biotechnology Co., Ltd.
- Hvsen Biotechnology Co., Ltd. announced a financing transaction